Navigation Links
Isis Reports Financial Results and Highlights for Third Quarter 2010
Date:11/4/2010

onths ended September 30, 2010 were $37.6 million and $114.6 million, respectively, compared to $37.2 million and $105.2 million for the same periods in 2009.  

Net Loss from Continuing Operations Attributable to Isis Pharmaceuticals, Inc. Common StockholdersNet loss from continuing operations for the three and nine months ended September 30, 2010 was $12.5 million and $47.3 million, respectively, compared to $11.6 million and $15.2 million for the same periods in 2009.  The increase in Isis' net loss from continuing operations for the nine months was primarily due to the following:

  • $22.5 million increase in net operating loss, excluding Regulus, as described above;
  • $3.4 million increase in Isis' share of Regulus' net loss;
  • $2.7 million decrease in investment income due to a lower average return on investments resulting from the current market conditions and a lower average cash balance; and
  • $880,000 non-cash loss that Isis recognized in 2010 related to the impairment of its equity investment in Antisense Therapeutics Limited compared to a $2.5 million gain in 2009 from the sale of OncoGenex common stock that Isis owned.

  • Net Income (Loss)Isis reported a net loss of $12.5 million and $47.3 million for the three and nine months ended September 30, 2010, respectively, compared to a net loss of $11.6 million for the three months ended September 30, 2009 and net income of $171.9 million for the nine months ended September 30, 2009.  Basic and diluted net loss per share for the three and nine months ended September 30, 2010 was $0.13 per share and $0.48 per share, respectively, compared to basic and diluted net loss per share of $0.12 for the three months ended September 30, 2009 and net income per share of $1.75 for the nine months ended September 30, 2009.  Net income and net income per share for the first nine months of 2009 primarily consisted of the $187.2 m
    '/>"/>

    SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    2. Spherix Reports Second Quarter Earnings
    3. Tapestry Reports Second Quarter 2007 Results
    4. Callisto Reports on Second-Quarter 2007 Milestones
    5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
    6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
    7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
    9. Biopure Reports on Meeting with the FDA
    10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
    11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/18/2014)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ... Drug Administration (FDA) has removed the clinical hold ... SWOG,s ongoing Phase 1b/2 clinical trial (S1313). The ... PEGPH20 (PEGylated Recombinant Human Hyaluronidase) in combination with ... pancreatic adenocarcinoma.  The study will resume under a ...
    (Date:9/18/2014)... 2014 Australian biomarker discovery company Minomic International ... its MiStat™ prostate cancer screening test, planning to achieve ... completion. Minomic,s proprietary MiStat™ technology is a ... proprietary biomarker known as the MIL-38 antigen. This biomarker ... Researchers at 11 leading urology centres ...
    (Date:9/18/2014)... , Sept. 18, 2014 /CNW/ - A new expert ... Canada , released today by the ... safe and effective medicines for children. Each year about ... children use at least one prescription drug. Much of ... from the authorized use), creating potential health risks. ...
    Breaking Medicine Technology:SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3
    ... 17, 2011 Pharmatek Laboratories, Inc., a premier ... industry, announced that it has been approved by ... the analysis of Schedules I through V controlled ... manufacture drug products containing Schedules IV and V ...
    ... 2011 The U.S. Food and Drug Administration today ... with methotrexate, for the treatment of active systemic ... years and older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... a rare, potentially life-threatening disorder in children that ...
    Cached Medicine Technology:Pharmatek Granted Approval by the DEA for Analysis of All Controlled Substances 2FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis 2FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis 3
    (Date:9/18/2014)... Schaumburg, IL (PRWEB) September 18, 2014 ... proving itself a boon to contractors and homeowners ... construction dust that overtakes the home, causes potential ... project. Now available nationwide, the BuildClean system allows ... from demolition, sanding and other standard remodeling tasks. ...
    (Date:9/18/2014)... VA (PRWEB) September 18, 2014 Results ... just been released and it reveals that pornography is ... and also harms marriages. The findings are based upon ... ) and conducted by Barna Group among a nationally ... survey included numerous questions focusing upon the frequency of ...
    (Date:9/18/2014)... Randy Dotinga HealthDay Reporter ... who have the largest number of post-traumatic stress disorder symptoms ... to food, a new study suggests. The findings ... or becoming addicted to food. And it,s also possible that ... PTSD, or both. Still, the research seems to ...
    (Date:9/18/2014)... Recently, WowBobble.com, the popular online supplier of funny ... to its product line. Moreover, all the company’s products ... customers can enjoy the special offer before September 29, 2014. ... prices ($12.5 for each bobblehead doll ). , ... bobbleheads. We want to make our interesting items available to ...
    (Date:9/18/2014)... September 18, 2014 A positive outlook on ... improve your health. This year, at the Weekend for Women ... that adored LA radio talk show host Mother Love will ... with diabetes. , The always-funny Jo Anne Hart, aka ... best known for her widely acclaimed talk show on LATalkRadio.com, ...
    Breaking Medicine News(10 mins):Health News:New BuildClean™ System Brings Livability Back to Home Remodeling 2Health News:New BuildClean™ System Brings Livability Back to Home Remodeling 3Health News:New BuildClean™ System Brings Livability Back to Home Remodeling 4Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 2Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 3Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 4Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 5Health News:PTSD Link to Food Addiction Seen in Report 2Health News:PTSD Link to Food Addiction Seen in Report 3Health News:Discounted Custom Bobbleheads Online For Sale At WowBobble.com 2Health News:DiabetesSisters Showcases Radio Talk Show Host Mother Love at Weekend for Women Conference in Los Angeles 2
    ... male and rural most likely to face obstacles, research ... veterans continue to meet barriers as they seek treatment ... and 2008, nearly 50,000 veterans from the Iraq and ... fewer than 10 percent of those completed the recommended ...
    ... , NEW YORK , ... ), the leading source of health information, today announced a ... in diagnosis and treatment at the point-of-care. Medscape Mobile, WebMD,s ... of in-depth clinical reference articles on diseases, conditions, and procedures, ...
    ... DALLAS Feb. 15, 2010 Simple urine tests for ... in people with lupus, researchers at UT Southwestern Medical Center ... take years before such tests could be used clinically, the ... currently in use, the researchers said. "Our goal was ...
    ... ... with healthcare companies to develop customized, corporate branded accredited programs for patient safety, fall ... ... MedicalNurseTraining.com announces an exciting new way to bundle Health Care Brands as an ...
    ... ... Atlanta-based Premier Anesthesia to manage the anesthesia services for its hospital and surgery center. ... Alpharetta, GA ... has contracted with Atlanta-based Premier Anesthesia to manage the anesthesia services for its hospital ...
    ... , LYON, France ... a new line of TCS 7560 and TCS 7561 Silbione(R) ... applications (support,stockings and medical equipment). These two new silicone elastomers ... (Photo: http://www.newscom.com/cgi-bin/prnh/20100216/377913 ) , ...
    Cached Medicine News:Health News:WebMD Launches New Version of Free Mobile Application for Physicians 2Health News:WebMD Launches New Version of Free Mobile Application for Physicians 3Health News:WebMD Launches New Version of Free Mobile Application for Physicians 4Health News:Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find 2Health News:Medical Nurse Training, Inc. Partners With Healthcare Companies to Develop Corporate Branded, Accredited Programs for Patient/Bed Safety and Fall Prevention/Protection 2Health News:Premier Anesthesia Forges New Partnership with Texas Hospital 2Health News:Bluestar Silicones Launches a New Range of Silbione(R) TCS 7560 & 7561 Elastomers for Lingerie, Support Stockings and Medical Textile Applications 2
    ... two-piece Titanium (Ti-6Al-4V) screw offered in two ... of lengths. The two pieces are loaded ... A single instrument set contains all items ... Standard and Mini Kompressor Compression Screws. , ...
    ... The cornerstones of the Acutrak family ... Screw Systems. Together they are used primarily ... of the upper extremity, but have been ... The bones stabilized with these two systems ...
    ... combined with the IRIS Medical OcuLight ... consoles,the EasyView slit lamp adapter (SLA) ... laser photocoagulation,to your existing Haag-Streit slit ... and glaucoma,without compromising the diagnostic functions ...
    ... revolutionized the wrist arthroplasty market with the ... We're at it again, with the release ... Like the original, the Universal2 System continues ... debilitating arthritis. To date, we now have ...
    Medicine Products: